BioScrip Inc Stock Deutsche Boerse AG
Equities
US09069N1081
Healthcare Facilities & Services
Sales 2024 * | 4.75B 4.38B | Sales 2025 * | 5.18B 4.77B | Capitalization | 5.18B 4.78B |
---|---|---|---|---|---|
Net income 2024 * | 203M 187M | Net income 2025 * | 234M 216M | EV / Sales 2024 * | 1.22 x |
Net Debt 2024 * | 598M 551M | Net Debt 2025 * | 400M 369M | EV / Sales 2025 * | 1.08 x |
P/E ratio 2024 * |
25.7
x | P/E ratio 2025 * |
22.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.86% |
Latest transcript on BioScrip Inc
Managers | Title | Age | Since |
---|---|---|---|
John Rademacher
CEO | Chief Executive Officer | 57 | 19-08-05 |
Michael Shapiro
DFI | Director of Finance/CFO | 53 | 14-12-31 |
Caroline Budde
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Kraemer
CHM | Chairman | 69 | 19-08-06 |
David Golding
BRD | Director/Board Member | 62 | 15-04-30 |
John Arlotta
BRD | Director/Board Member | 74 | 19-08-06 |
1st Jan change | Capi. | |
---|---|---|
+25.52% | 88.99B | |
-24.52% | 74.82B | |
+0.49% | 25.03B | |
+4.31% | 17.88B | |
-14.25% | 16.43B | |
+2.97% | 15.77B | |
+79.20% | 13.21B | |
+70.11% | 13.08B | |
+40.44% | 12.9B |